Search Results 301-310 of 16630 for alopecia
Patients should have improvement of any toxic effects of prior therapy (except alopecia, fatigue, and other non-reversible toxic effects such as neuropathy ...
Resolution of all acute adverse events resulting from prior cancer therapies to NCI CTCAE grade ≤ 1 or baseline (except alopecia); Adequate organ function ...
... alopecia). Active uncontrolled bacterial, viral, or fungal infection requiring systemic therapy. Known history of testing positive for human ...
Patients with vitiligo or alopecia;; Patients with hypothyroidism (e.g., following Hashimoto syndrome) stable on hormone replacement or psoriasis not ...
Recovery to Grade 1 of any clinically significant toxicity attributed to prior anticancer therapy (excluding alopecia) prior to initiation of study drug ...
With the exception of alopecia, and CTCAE Grade 2 neuropathy, any unresolved toxicities from prior therapy > Grade 1 at the time of starting study treatment.
Cancer that forms in the germ-fighting lymphatic system is called lymphoma. Types of lymphoma include Hodgkin lymphoma and non-Hodgkin lymphoma.
Learn more about how damaged hair follicles become infected. This condition may clear up on its own, but severe infections can cause scarring or hair loss.
Participants with Grade 2 neuropathy or Grade 2 alopecia are eligible. - Active idiopathic thrombocytopenic purpura. - Stem cell transplant < 100 days prior ...
Patient must be able to have recovered from all toxicities associated with chemoradiotherapy for anal cancer, to Grade ≤ 1 with the exception of alopecia.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your World Cancer Day gift can go 4X as far.